secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0000950170-24-092011
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iterum Therapeutics rights offering expires; expects $7.4M gross proceeds
-------------------------------------------------------------------------

- Rights offering expired Aug 6, 2024; gross proceeds est. $7.4M, net ~$6.3M after $1.1M expenses.
- 17,007,601 rights distributed; each allowed purchase of 0.50 Units at $0.605.
- Basic subscription: 6,121,965 Units; over-subscription of 5,091,550 Units fully honored.
- Each Unit includes 1 share, 0.50 1-yr warrant ($1.21 strike), and 1 5-yr warrant ($1.21).
- Shares and warrants expected to be delivered on or about Aug 9, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000095017024092011/0000950170-24-092011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000095017024092011/itrm-20240806.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-092011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer